He added that similar tests are also planned for Australia, Thailand and Malaysia.
The vaccine was administered with good results to more than 1,000 patients in Cuba and it has also been registered in Peru and it is in the process of registration in other Latin American countries such as Colombia, Brazil, Paraguay, Ecuador and Argentina.
Zoraida Acosta, a researcher at the Center for Molecular Immunology, said the vaccine has no severe side effects and increases the patient’s life expectancy with a good quality of living. It cannot prevent the onset of the disease but will allow advanced cancer to be controlled by generating antibodies against the proteins that trigger the uncontrollable processes of cellular proliferation.
Cuban scientists believe that the product’s same basic principle could be used to treat other cancers, including prostate, uterus, and breast cancers.